Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

✍ Scribed by Macerelli, M.; Caramella, C.; Faivre, L.; Besse, B.; Planchard, D.; Polo, V.; Ngo Camus, M.; Celebic, A.; Koubi-Pick, V.; Lacroix, L.; Pignon, J.P.; Soria, J.C.

• Book ID: 122282286
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 924 KB
• Volume: 83
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2013.12.013